| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Benefit and harm of deceased- or living-donor liver transplantation for hepatocellular carcinoma
|
Cillo, U.
|
|
2009
|
3 |
4 |
p. 88-92
5 p.
|
artikel
|
| 2 |
De-novo hepatitis B virus infection in transplants: Risk factors and anti-hepatitis B immunoglobulin prophylaxis
|
Marzano, A.
|
|
2009
|
3 |
4 |
p. 104-107
4 p.
|
artikel
|
| 3 |
Editorial Board
|
|
|
2009
|
3 |
4 |
p. i-
1 p.
|
artikel
|
| 4 |
Evaluation of graft and recipient risk factors in liver transplantation
|
Burra, P.
|
|
2009
|
3 |
4 |
p. 108-111
4 p.
|
artikel
|
| 5 |
Hyperimmune immunoglobulins: Manufacturing technologies and safety procedures
|
Marzo, N.
|
|
2009
|
3 |
4 |
p. 112-118
7 p.
|
artikel
|
| 6 |
Intravenous versus intramuscular route: How to choose
|
Fagiuoli, S.
|
|
2009
|
3 |
4 |
p. 124-128
5 p.
|
artikel
|
| 7 |
Liver transplantation from donors after cardiac death
|
Fondevila, C.
|
|
2009
|
3 |
4 |
p. 82-87
6 p.
|
artikel
|
| 8 |
Liver Transplantation Interdisciplinary Conference (2)
|
Rizzetto, Mario
|
|
2009
|
3 |
4 |
p. 74-
1 p.
|
artikel
|
| 9 |
Liver Transplantation Interdisciplinary Conference (1)
|
Arroyo, Vicente
|
|
2009
|
3 |
4 |
p. 73-
1 p.
|
artikel
|
| 10 |
Liver transplantation: The Spanish experience
|
Matesanz, R.
|
|
2009
|
3 |
4 |
p. 75-81
7 p.
|
artikel
|
| 11 |
Pharmacokinetics of intramuscular and intravenous HBIG: Which implications for practice?
|
Castells, L.
|
|
2009
|
3 |
4 |
p. 119-123
5 p.
|
artikel
|
| 12 |
Pool expansion for organ procurement: Older donors for liver transplantation
|
Filipponi, F.
|
|
2009
|
3 |
4 |
p. 96-97
2 p.
|
artikel
|
| 13 |
Prevention of HBV recurrence after liver transplant: The role of combination therapy
|
Buti, M.
|
|
2009
|
3 |
4 |
p. 98-103
6 p.
|
artikel
|
| 14 |
Split and living donor liver transplantation
|
García-Valdecasas, J.C.
|
|
2009
|
3 |
4 |
p. 93-95
3 p.
|
artikel
|
Tijdschrift beschrijving